A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results

dc.creatorKrauss-Silva, Leticia
dc.creatorMoreira, Maria Elisabeth Lopes
dc.creatorAlves, Mariane B.
dc.creatorBraga, Alcione
dc.creatorCamacho, Karla G.
dc.creatorBatista, Maria Rosa R.
dc.creatorAlmada-Horta, Antonio
dc.creatorRebello, Maria R.
dc.creatorGuerra, Fernando
dc.date2013-10-02T17:47:41Z
dc.date2013-10-02T17:47:41Z
dc.date2011
dc.date.accessioned2023-09-27T00:13:21Z
dc.date.available2023-09-27T00:13:21Z
dc.identifierKRAUSS-SILVA, Leticia et al. A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials, London, v. 12, n. 239, p. 1-11, 2011.
dc.identifier1745-6215
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/7035
dc.identifier10.1186/1745-6215-12-239
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8898667
dc.descriptionTrial registration at NIH register: NCT00303082. Sources of funding: the Brazilian Health Ministry and the State of Rio de Janeiro Research Foundation.
dc.descriptionBACKGROUND: Bacterial vaginosis increases the risk of spontaneous preterm delivery at less than 34 weeks of gestation. OBJECTIVE: The purpose of this study was to evaluate the efficacy of the early administration of selected lactobacilli strains (probiotics) to pregnant women with asymptomatic bacterial vaginosis/intermediate-degree infections to prevent spontaneous premature delivery and associated neonatal morbidity. METHODS/DESIGN: Asymptomatic pregnant women at less than 20 weeks of gestation, with no indication of elective preterm delivery, with a vaginal pH ≥ 4.5 and Nugent score > 3 were randomly assigned to the placebo or intervention group (oral administration of selected lactobacilli up to the 24th to 26th week of gestation). The randomisation was stratified for the history of premature delivery (HPD) and blocked. The allocation was concealed, and the participating health professionals and patients were blinded. The primary outcome was preterm delivery (<34 to <32 weeks), and the secondary outcomes were associated neonatal complications. RESULTS: In total, 4,204 pregnant women were screened; 320 and 324 individuals were respectively randomly assigned to the placebo and intervention groups, and 62% finished the trial. None of the randomised patients were lost to follow-up. For the non-HPD stratum, the intent-to-treat relative risks of spontaneous premature birth at < 34 and < 37 weeks' gestation were 0.33 (0.03, 3.16) and 0.49 (0.17, 1.44), respectively, and they were non-significant (ns) with p = 0.31 and 0.14. The corresponding actual treatment figures were zero and 0.32 (0.09, 1.19), which were ns with p = 0.12 and 0.06. The intent-to-treat relative risk of spontaneous premature birth at < 37 weeks of gestation for the trial as a whole, including HPD and non-HPD participants, was 0.69 (0.26, 1.78), p = 0.30 (ns). The neonatal complications under evaluation occurred in only one infant (< 34 weeks; placebo group) who presented with respiratory distress syndrome and suspected early neonatal sepsis. The recorded adverse events were minor and relatively non-specific. CONCLUSIONS: The efficacy of the tested probiotics to prevent preterm delivery among women without a history of preterm delivery was not determined because the study sample was insufficient to estimate statistically significant intent-to-treat effects; additional studies are needed to evaluate this intervention among these women.
dc.formatapplication/pdf
dc.languageeng
dc.publisherBioMed Central
dc.relationAgency for Healthcare Research and Quality: Management of preterm labor. Evidence report/technology assessment n. 18, AHRQ public n. 01-E021 2000.
dc.relationLeal MC, Gama SGN, Campos MR: Fatores associados à morbi-mortalidade perinatal em uma amostra de maternidades públicas e privadas do município do Rio de Janeiro, 1999-2001. Cadernos de Saúde Pública 2004, 20(Supl 1):S20-S33.
dc.relationCampos MR, Leal MC, Souza PR Jr, Cunha CB: Consistência entre fontes de dados e confiabilidade inter-observador do estudo da morbimortalidade e atenção peri e neonatal no município do Rio de Janeiro. Cadernos de Saúde Pública 2004, 20(Supl 1):S34-S43.
dc.relationBerkowitz GS, Prince CB, Lapinski RH: Risk factors for preterm birth subtypes. Epidemiology 1998, 9(3):279-285.
dc.relationGoldenberg RL, Andrews WW, Hauth JC: Choriodecidual infection and preterm birth. Nutrition Reviews 2002, 60(5):S19-S25.
dc.relationRomero R, Espinoza J, Chaiworapongsa T, Kalache K: Infections and prematurity and the role of preventive strategies. Semin Neonatol 2002, 7:259-274.
dc.relationGoldenberg RL, Iams JD, Mercer BM, Meis P, Moawad A, Das A, Copper R, Johnson F, for the national Institute of Child Health and Human Development Network: What we have learned about the predictors of preterm birth. Seminars in Perinatology 2003, 27(3):185-93.
dc.relationMercer BM, Goldenberg RL, Das A: The preterm prediction study: A clinical risk assessment system. Am J Obstet Gynecol 1996, 174(6):1885-1895.
dc.relationKlebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, Iams JD, Moawad A, Miodovnik M, Sibai BM, van Dorsten JP, Dombrowski MP, for the National Institute for Child Health and Development Maternal Fetal Medicine Units Network: Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. American Journal of Obstetrics and Gynecology 2004, 190(2):363-70.
dc.relationYoon BH, Romero R, Park JS, Kim M, Oh SY, Jun JK: The relationships among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol 2000, 183(5):1124-9.
dc.relationYoon BH, Romero R, Kim KS: Transactions of the nineteenth annual meeting of the society for maternal-fetal medicine. Am J Obstet Gynecol 1999, 181(4):773-9.
dc.relationYoon BH, Romero R, Yang SH: Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174(5):1433-40.
dc.relationGomez R, Romero R, Ghezzi F: The Fetal Inflammatory Response Syndrome. Am J Obstet Gynecol 1998, 179(1):194-202.
dc.relationCauci S: Vaginal Immunity in Bacterial Vaginosis. Current Infectious Disease Reports 2004, 6(6):450-6.
dc.relationMcGregor JÁ, French JI, Richter R: Cervicovaginal microflora and pregnancy outcome: results of double-blind, placebo-controlled trial of erythromycin. Am J Obstet Gynecol 1990, 163(5 Pt 1):1580-91.
dc.relationHauth JC, Goldenberg RL, Andrews WW: Reduced Incidence of Preterm Delivery With Metronidazole and Erythromycin in Women with Bacterial Vaginosis. N Engl J Med 1995, 333(26):1732-6.
dc.relationCarey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, Miodovnik M, Dombrowski M, O’Sullivan MJ, van Dorsten JP, Langer O, Roberts J: Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal and Fetal Medicine Units. N Engl J Med 2000, 343(8):534-40.
dc.relationAndrews WW, Sibai BM, Thom EA, Dudley D, Ernest JM, McNellis D, Leveno KJ, Wapmer R, Moawad A, O’Sullivan MJ, Caritis SN, Iams JD, Langer O, Miodovnik M, Dombrowski M, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network: Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003, 101(5):847-55.
dc.relationSimhan HN, Caritis SN, Krohn MA, Tejada BM, Landers DV, Hillier SL: Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003, 189(2):560-7.
dc.relationRomero R, Chaiworapongsa T, Kuivaniemi H, Tromp G: Bacterial Vaginosis. The inflammatory response and the preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol 2004, 190(6):1509-19.
dc.relationKlein LL, Gibbs R: Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol 2004, 190:1493-502.
dc.relationIsolauri E, Salminen S, Ouwehand AC: Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol 2004, 18(2):299-313.
dc.relationVrese M, Schrezenmeir J: Probiotics and non-intestinal infectious conditions. Br J Nutr 2002, 88(Suppl 1):S59-S66.
dc.relationReid G, Devillard E: Probiotics for mother and child. J Clin Gastroenterol 2004, 38(Suppl 2):S94-S101.
dc.relationReid G, Bocking A: The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003, 189(4):1202-8.
dc.relationReid G, Charbonneau D, Erb J, Beuerman D, Poehner R, Bruce AW: Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbio 2003, 35:131-4.
dc.relationReid G, Beuerman D, Heinemann C, Bruce AW: Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbio 2001, 32:37-41.
dc.relationReid G, Bruce AW: Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 2001, 183(Suppl 1):S77-80.
dc.relationReid G, Bruce AW, Fraser N: Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbio 2001, 30:49-52.
dc.relationKrauss-Silva , et al: Reproductive Health 2010, 7:14[http://www.reproductivehealth- journal.com/content/7/1/14].
dc.relationNugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiology 1991, 29(2):297-301.
dc.relationVermont Oxford Network. Database Manual of Operations. >Release 5.0. Burlington, VT 2000.
dc.relationAltman DG, Schulz KF, Moher D, Egger M, et al: The Revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001, 134:663-694.
dc.relationMoher D, Hopewell S, Schulz KF, Montori V, et al: CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomized trials. BMJ 2010, 340.
dc.relationSchulz KF, Altman DG, Moher D, for the CONSORT Group: CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomized trials. Trials 2010, 11:32.
dc.relationMeis PJ, Goldenberg RL, Mercer B, et al: The Preterm Prediction Study: significance of vaginal infections. Am J Obst Gynecol 1995, 173:1231-5.
dc.relationHauth JC, Macpherson C, Carey JC, Klebanoff MA, Hillier SL, Ernest JM, Leveno KJ, Wapner R, Varner M, Trout W, Moawad A, Sibai BM, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network: Early pregnancy threshold vagina pH and gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol 2003, 188(3):831-5.
dc.relationSimhan HN, Caritis NS, Krohn MA, Hillier SL: Elevated Vaginal pH And Neutrophils Are Associated Strongly with Early Spontaneous Preterm Birth. Am J Obstet Gynecol 2003, 189(4):1150-4.
dc.relationMonga M, Blanco J: Intrauterine Infection and Preterm Labor. Inf Dis Obstet Gynecol 1995, 3:37-44.
dc.relationMercer BM: Preterm Premature Rupture of Membranes. Obstet Gynecol 2003, 101:178-193.
dc.relationRomero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM: A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet and Gynecol 1998, 179(10):186-93.
dc.relationGoldenberg R, Culhane JF, Iams J, Romero R: Epidemiology and causes of preterm birth. The Lancet 2008, 371:75-84.
dc.relationCloherty JP, Eichenwald EC, Stark AR: Manual of Neonatal Care. Lippincott Williams & Wilkins; Fifth edition, Philadelphia; 2004.
dc.relationPahlson C, Larsson PG: The ecologically wrong vaginal lactobacilli. Medical Hypotheses 1991, 36:126-130.
dc.relationFamularo G, Pieluigi M, Coccia R, Mastroiacovo P, De Simone C: Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses 2001, 56(4):421-30.
dc.relationMcLean NW, Rosenstein IJ: Characterization and selection of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000, 49:543-52.
dc.relationIams JD, Goldenberg RL, Mercer BM, Moawad A, Das AF, Caritis SN, Miodovnik M, Menard MK, Thurnau GR, Dombrowski M, Roberts J, for the National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network: The Preterm Prediction Study: Can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol 2001, 184(4):652-655.
dc.relationGenc MR, Witkin SS, Delaney ML, Paraskevas LR, Tuomala RE, Norwitz ER, Onderdonk AB: A disproportionate increase in IL-1B over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstetrics Gynecology 2004, 190(5):1191-1197.
dc.relationKalinka J, Sobala W, Wasiela M, Brzezinska-Błaszczyk E: Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery. AJRI 2005, 54:70-76.
dc.relationPochard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A: Lactic acid bacteria inhibit Th2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002, 110(4):617-23.
dc.rightsopen access
dc.subjectSpontaneous Preterm Delivery
dc.subjectPrevention
dc.subjectRandomised Controlled parallel-group Trial
dc.subjectProbiotics
dc.subjectHistory of Preterm Delivery
dc.subjectNascimento Prematuro - /prevenção & controle
dc.subjectProbióticos - uso terapêutico
dc.subjectVaginose Bacteriana - quimioterapia
dc.subjectGravidez
dc.subjectRecém-Nascido
dc.titleA randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results
dc.typeArticle


Este ítem pertenece a la siguiente institución